FBXO28: F-Box Protein 28
A substrate recognition component of the SCF ubiquitin ligase complex involved in cell cycle control and tumorigenesis.
Gene Information Card
| Symbol | FBXO28 |
|---|---|
| Full Name | F-box protein 28 |
| Gene Type | protein-coding |
| Chromosomal Location | 1q42.1 |
| NCBI Gene ID | 23219 ncbi.nlm.nih.gov/gene/23219 |
| Ensembl ID | ENSG00000143756 |
| UniProt ID | Q9NVF7 |
| OMIM ID | 609100 |
| HGNC ID | 13586 |
| Aliases | Fbx28, FBX28, F-box only protein 28 |
Description
FBXO28 encodes a member of the F-box protein family, characterized by an F-box motif. F-box proteins constitute one of the four subunits of the SCF (SKP1-cullin-F-box) ubiquitin ligase complex, which targets proteins for ubiquitination and subsequent proteasomal degradation. FBXO28 specifically recognizes and binds phosphorylated substrates, playing a critical role in cell cycle progression, DNA damage response, and transcriptional regulation. It has been implicated in the regulation of MYC stability and activity.
Disease Associations
| Disease category | Pathophysiological mechanism | Genomic evidence |
|---|---|---|
| Breast cancer | FBXO28 overexpression promotes MYC-driven tumorigenesis by enhancing MYC transcriptional activity and stability. | PMID: 26030138 |
| Colorectal cancer | FBXO28 is recurrently amplified and overexpressed, contributing to tumor cell proliferation. | COSMIC; PMID: 23535649 |
| Ovarian cancer | FBXO28 copy number gains and high expression correlate with poor prognosis. | PMID: 26030138 |
| Gastric cancer | FBXO28 upregulation associated with aggressive tumor features. | PMID: 28708998 |
Expression Profile
Tissue Expression
| Tissue | nTPM | level |
|---|---|---|
| Testis | 12.5 | Medium |
| Lymph node | 10.2 | Medium |
| Bone marrow | 9.8 | Medium |
| Brain | 4.3 | Low |
| Liver | 3.1 | Low |
Cell Line Expression
| Cell Line | nTPM | Notes |
|---|---|---|
| HeLa | 15.6 | Cervical cancer cell line |
| MCF7 | 14.2 | Breast cancer cell line |
| HCT116 | 13.8 | Colorectal cancer cell line |
| HEK293 | 11.5 | Embryonic kidney cell line |
| K562 | 9.4 | Leukemia cell line |
Data source:Human Protein Atlas(proteinatlas.org)
Mutations & Variants
Hotspot Mutations
| Variant | Type | Frequency | Functional Description |
|---|---|---|---|
| c.1015C>T (p.Arg339Trp) | Missense | <0.1% | Unknown functional effect; reported in COSMIC |
| c.1246G>A (p.Glu416Lys) | Missense | <0.1% | Unknown functional effect; reported in COSMIC |
| Amplification | Copy number gain | ~5-10% in breast cancer | Associated with increased FBXO28 expression and poor prognosis |
Mutation functional classification
Loss of Function (LOF)
No confirmed loss-of-function mutations reported in major databases.
Gain of Function (GOF)
Amplification and overexpression are considered gain-of-function events, enhancing MYC activity.
Dominant Negative (DN)
Not described for FBXO28.
View complete mutation data:
Gene Ontology (GO)
Pathways
• SCF ubiquitin ligase complex pathway (Reactome: R-HSA-8951664)
• Ubiquitin-mediated proteolysis (KEGG: hsa04120)
• MYC transcriptional regulation (Reactome: R-HSA-212436)
Protein Summary
FBXO28 is a 469-amino acid F-box protein that functions as the substrate recognition component of the SCF ubiquitin ligase complex. It contains an N-terminal F-box domain (residues 1-40) that mediates binding to SKP1, and a C-terminal substrate-binding domain. FBXO28 targets phosphorylated proteins for ubiquitination, with key substrates including MYC. By regulating MYC stability and transcriptional activity, FBXO28 influences cell proliferation, differentiation, and tumorigenesis. The protein is predominantly nuclear and is expressed in multiple tissues, with highest levels in testis and lymphoid organs.
Related Services
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| FBXO28 Knockout HEK293 Cell Line | EDJ-KQ7892 | Human | 23219 | Details Get a Quote |
| FBXO28 Knockout A-549 Cell Line | EDJ-KQ33488 | Human | 23219 | Details Get a Quote |
| FBXO28 Knockout HCT 116 Cell Line | EDJ-KQ33489 | Human | 23219 | Details Get a Quote |
| FBXO28 Knockout HeLa Cell Line | EDJ-KQ33490 | Human | 23219 | Details Get a Quote |
| Fbxo28 Knockout HBZY-1 Cell Line | EDJ-KZ246 | Rat | 23219 | Details Get a Quote |